Overview

Tenelia Elderly CGMS Study(TEDDY)

Status:
Active, not recruiting
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.